SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-034482
Filing Date
2021-06-28
Accepted
2021-06-28 16:57:38
Documents
38
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0321_orionbiotech.htm 10-Q 295961
2 CERTIFICATION f10q0321ex31-1_orionbio.htm EX-31.1 12402
3 CERTIFICATION f10q0321ex31-2_orionbio.htm EX-31.2 12681
4 CERTIFICATION f10q0321ex32-1_orionbio.htm EX-32.1 4664
5 CERTIFICATION f10q0321ex32-2_orionbio.htm EX-32.2 4675
  Complete submission text file 0001213900-21-034482.txt   1779862

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE oria-20210331.xml EX-101.INS 175767
7 XBRL SCHEMA FILE oria-20210331.xsd EX-101.SCH 28906
8 XBRL CALCULATION FILE oria-20210331_cal.xml EX-101.CAL 10102
9 XBRL DEFINITION FILE oria-20210331_def.xml EX-101.DEF 126876
10 XBRL LABEL FILE oria-20210331_lab.xml EX-101.LAB 212725
11 XBRL PRESENTATION FILE oria-20210331_pre.xml EX-101.PRE 128678
Mailing Address 645 FIFTH AVENUE, 21ST FLOOR NEW YORK NY 10022
Business Address 645 FIFTH AVENUE, 21ST FLOOR NEW YORK NY 10022 212-303-7822
Orion Biotech Opportunities Corp. (Filer) CIK: 0001847416 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40410 | Film No.: 211054230
SIC: 6770 Blank Checks
Office of Real Estate & Construction